3-triazol-1-yl]-1-thio-α-D-galactopyranoside clinical trials

An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condition and a tablet under fasting and fed conditions in healthy volunteers.

This study is testing a new medicine in healthy volunteers. It looks at how the body handles the medicine when given in different forms (capsule or tablet) and with or without food. The aim is to understand how the medicine behaves in the body.